Drug Profile
Research programme: stem cell therapy - Bio-Matrix Scientific
Alternative Names: Adipose-derived stem cell therapy; ASC therapyLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bio-Matrix Scientific Group
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Brain injuries; Chronic obstructive pulmonary disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Brain injuries in USA (Intracerebral)
- 16 Jul 2016 No recent reports of development identified for research development in Brain injuries in USA (IV)
- 16 Jul 2016 No recent reports of development identified for research development in Chronic-obstructive-pulmonary-disease in USA (Parenteral)